2021

Scientifically Speaking: New Directions in Ance Management Series – Part 2

Watch Dr. Tanghetti discuss Accure with Joel L. Cohen, MD; Diane Berson, MD; and Linda Stein Gold, MD; about the best practices in acne care, with a focus on identifying and countering misinformation.

Practical Dermatology, June 9, 2021

2021

Dr. Tanghetti’s Advice About Sun Protection

2021

Journal of Drugs in Dermatology

Tazarotene 0.045% Lotion for Moderate-to-Severe Acne Patients: Pooled Phase 3 Analysis by Age and Sex

June 2021 | Volume 20 | Issue 6 | Original Article | 608 | Copyright © June 2021

2020

Dr. Tanghetti’s Perspective on Telehealth

How does Telehealth compare to the traditional in-person visit in a busy dermatology practice? Dr. Emil Tanghetti shares his perspective on Telehealth with The Dermatologist. View the full article.

2020

2020

Dr. Tanghetti’s research published in the Journal of the European Academy of Dermatology and Venereology, is among the top 10% most downloaded papers in the journal. ⁠Long‐term safety and efficacy of trifarotene 50 μg/g cream, a first‐in‐class RAR‐γ selective topical retinoid, in patients with moderate facial and truncal acne
⁠

2019

Tan, J., Tanghetti,E., Baldwin, H., Stein Gold, L. Lain, E., The Role of Topical Retinoids in Prevention and Treatment of Atrophic Acne Scarring: Understanding the Importance of Early Effective Treatment. J Drug Dermatol. 2019 18(3) 255-264.

2018

Tanghetti,E.A., Harper, J., Baldwin,H., Kircik, L., Bai, Z., Alvandi,N. . Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females. J Drug Dermatol. 2018l 17(11) 1032-1038.

2018

Stein-Gold, L.,Kircik, L., Draelos, Z., Werschler P., DuBois,J., Lain,E., Baumann, L., Goldberg,D., Kaufman, J.,Tanghetti, E.A., Ahluwalia, G.,  Alvandi,N.,  Weng, E., Berk, D Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials. J Drug Dermatol.

2018

Stockton, T., Tanghetti, E.A, Lain, E., Zeichner, J., Alvandi, N. Clinical experience with once-daily dapsone gel, 7.5% monotherapy in patients with acne vulgaris. J Drug Dermatol. 2018; 17(6): 602-608.

2018

Tanghetti, E., Dover, J., Goldberg,D., Dhawan,S., Luo, L., Berk, D., Ahluwalia, G., Alvandi,N. Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0%. J Drug Dermatol. 2018; 17(6): 621-626

2018

Del Rosso JQ, Stein Gold L, Johnson SM, Rueda MJ, Baldwin H, Lain EL, Landis M, Rendon M, Tanghetti E, Weiss J. Efficacy and Safety of Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel Plus Oral Doxycycline in Subjects With Severe Inflammatory Acne Who Are Candidates for Oral Isotretinoin. J Drugs Dermatol. 2018 Mar 1;17(3):264-273

2018

Baumann L, Goldberg DJ, Stein Gold L, Tanghetti EA, Lain E, Kaufman J, Weng E, Berk DR, Ahluwalia G.Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.J Drugs Dermatol. 2018 Mar 1;17(3):290-298

2018

Tanghetti, E., Jennings, J. A compartative study with a 755nm picosecond Alexandrite laser with a diffractive lens array and a 532nm/1064nm Nd:YAG with a holographic optic. Laser in Surgery and Medicine.  Vol 50 (1). 33-44

2017

Del Rosso JQ, Tanghetti EA, Baldwin HE, Rodriguez DA, Ferrusi IL.The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey. J Clin Aesthet Dermatol. 2017 Jun;10(6):17-31. Epub 2017 Jun 1

2017

Short-pulsed laser for the treatment of tattoos, pigmented lesions, scars and rejuvenation. Tanghetti EA, Hoffmann KA, Hoffmann K. Semin Cutan Med Surg. 2017 Dec;36(4):148-154. doi: 10.12788/j.sder.2017.032

2017

Siegel D, Tanghetti E, Brody N,Freeman M, Skov T, Petersen A, Clonier F Spelman L. Ingenol Mebutate 0.06% Gel for Field Treatment of Actinic Keratosis on 250 cm2 of Skin on Trunk and Extremities: A Randomized Dose-Finding Trial. Journal of Cutaneous Medicine. Vol 1;3: 128 – 140

2017

Tanghetti, E.A., Kircik, L., Baldwin, H., Harper, J., Fu, Y., Alvandi, N. Once-Daily Topical Dapsone Gel 7.5% Is More Effective in Females Regardless of Baseline Acne Lesion Count. Presented at: Clinical Dermatology Conference, October 12-15, 2017. Las Vegas, NV.

2017

Tanghetti, E.A, Jennings, J. Clinical and histologic comparative study with a 755nm picosecond Alexandrite laser with a diffractive lens array and a 532nm/1064nm Nd:YAG with a holographic optic. Laser in Surgery and Medicine. Vol 49 (9)

2016

Tanghetti, E.A., Tartar, D.M., Comparison of the Cutaneous Thermal Signatures Over Twenty-Four Hours With a Picosecond Alexandrite Laser Using a Flat or Fractional Optic. JDD. 2016; 15 (11):611-616

2016

Tanghetti, E.A., The Histology of Skin Treated with a Picosecond Alexandrite Laser and a Fractional Lens Array. Lasers in Surgery and Medicine. 2016;48(7): 646-52

2016

Tanghetti, E.A, Mirkov, M, Sierra, R.A. Delivery of Light to the Skin Through Ablated Conduits. Lasers in Surgery and Medicine. 2016 (48):4

2016

Tanghetti, E.A.:.Comparative Cutaneous Histology From the Treatment Using a Picosecond Alexandrite and Nd:YAG Laser with a Fractional Options. 2016 Annual ASLMS Conference Presentation/Abstract, Boston, MA.

2016

Tanghetti, E.A.:. The Immediate Clinical and Thermal Findings Associated with the Use of a Picosecond Alexandrite laser With a Flat and A Fractional Optic. 2016 Annual ASLMS Conference Presentation/Abstract, Boston, MA.

2016

Stein Gold L, Weiss J, Rueda Jose M, Liu H, Tanghetti E, Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study. Am J Clin Dermatol 2016; 17(3):293-303

2015

Weiss J, Stein L, Leoni M, Rueda MJ, Liu H, Tanghetti EA, Customized Single-agent Therapy Management of Severe Inflammatory Acne: A Randomized, Double-blind, Parrallel-group, Controlled Study of a New Treatment-Adapalene 0.3%-Benzoyl Peroxide 2.5% Gel. JDD Vol 14:12 1427-1435

2015

Tanghetti EA, Hamann C, Tanghetti M, A Controlled Comparison Study of Topical Fluourouracil 5% Cream Pre-Treatment of Aminolevulinic Acid/Photodynamic Therapy for Actinic Keratosis. JDD Vol 14:11 1241-1244

2015

Tanghetti, EA, et al. A Randomized, Double-Blind Trial to Investigate the Equivalence of IncobotulinumtoxinA and OnabotulinumtoxinA for Glabellar Frown Lines. ASDS November 2015 41:1310-1319

2015

Tanghetti EA, et al. Impact of Female Acne on Pattern of Health Care Resource Utilization JDD February 2015 Vol. 14 140-148

2015

Tanghetti EA, et al. Optimizing the Use of Topical Brimonidine in Rosacea Management: Panel Recommendations JDD January 2015 Vol. 14 33-40

2014

Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 5: A Guide on the Management of Rosacea. Cutis Vol 93:134-138

2014

Tanghetti EA,et al. Consensus Recommendations from the American Acne & Rosacea Society on the Management of Rosacea, Part 4: A Status Report on Physical Modalities and Devices. Cutis Vol 93:71-76

2014

Tanghetti EA, et al. Understanding the Burden of Adult Female Acne. JCAD February 2014 Vol 7 2:22-30

2014

Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 3: A Status Report on Systemic Therapies. Cutis Vol 93 1:18-28

2013

Tanghetti EA:The Role of Inflammation in the Pathology of Acne JCAD September 2013 Vol 6 91:27-35

2013

Tanghetti EA, et al: The Use of Topical 5-FU to Diagnose Subclinical Actnic Keratosis that Remain 3 Months after Three Different Actinic Keratosis Treatment Protocols. Poster Presented AAD March 2013

2013

Del Rosso JQ, Tanghetti, EA: A Status Report on Topical Tazarotene in the Management of Acne Vulgaris. JDD Vol 12;3:S53-s58

2013

Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 2: A Status Report on Topical Agents. Cutis Vol 92:277-284

2013

Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti EA et al: Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 1: A Status Report on the Disease State, General Measures, and Adjunctive Skin Care. Cutis Vol 92:234-240

2013

Del Rosso JQ, Gallo RL, Tanghetti EA, Webster G, Thiboutot D: An Evaluation of Potential Correlations Between pathophysiologic Mechanisms, Clinical manifestations, and Management of Rosacea. Cutis Vol 91 3S:1-8

2012

Tanghetti EA, Harper JC, Oefelein MG: The Efficacy and Tolerability of Dapsone 5% Gel in Female vs Male Patients with Facial Acne Vulgaris: Gender as a Clinically Relevant Outcome Variable. JDD Vol 11 12:1417-1421

2012

Baldwin HE, Daniels SR, Kawata AK, Burk CT Wilcox TK, Tanghetti EA: Acne Vulgaris in Adult Females: Healthcare Resource utilization for Treatment of Facial Acne. Poster Presented Fall Clinical 2012.

2012

Bikowski, J, Harper JC, Tanghetti EA, et al: Therapeutic Advances in the Topical Management of Acne. Practical Dermatology July 2012 Sup.

2012

Callendar VD, Daniels SR, Tanghetti EA, et al: Treatment satisfaction and psychosocial impact of acne in adult women. Poster NADNP 2012.

2012

Tanghetti EA, Callendar VD, Daniels SR, et al: Understanding Adult Women with Acne:A Web-Based Survey Assessing Burden of Acne in Adult Women. Poster Maui Derm 2012.

2012

Tanghetti, E.A.: Split-Face Randomized Treatment of Facial Telangiectasia Comparing Pulsed Dye Laser and an Intense Pulsed Light Handpiece. LSM 44:97-102

2011

Tanghetti, E.A. et al: Clinical Evidence for the Role of a Topical Anti-Inflammatory Agent in Comedonal Acne: Findings From a Randomized Study of Dapsone Gel 5% in Combination with Tazarotene Cream 0.1% in Patient with Acne Vulgaris JDD Vol 10 7:783-792

2011

Tanghetti, M.D.: Laser Hair Removal for Diverse Population with a Muti-plexed Dual Wavelength Device. 31^st Annual Conference ASLMS Poster.

2011

Tanghetti, E.A.: Split-Faced Randomized Treatment of Facial Telangiectasia Comparing Pulsed Dye Laser and a New Optimized Light Handpiece. 31^st Annual ASLMS Conference Presentation, Grapevine, TX.

2011

Tanghetti, E.A.: Lasers with non-Device Skin Treatment Interventions. ASLMS 2011 Annual Conference Fundamentals Course, Grapevine, TX.

2011

Weiss, RA; Ross, EV; Tanghetti, EA; et al: Characterization of an Optimized Light Source and Comparison to Pulsed Dye Laser for Superficial and Deep Vessel Clearance. Lasers in Surg and Med 43:92-98.

2011

Raulin, C.; Karsai, S. (eds): Laser and IPL Technology in Dermatology and Aesthetic Medicine, DOI: 10.1007/978-3-642-03438-1_16 Springer-Verlag Berlin Heidelberg 2011 Chapter 16 Common Vascular Lesions 227-240

2011

Tanghetti, E.A.:Pathogenesis of Psoriasis: Emerging Research, The Emerging Role of Vitamin D in Dermatology. PVupdates print/online presentation www.pvupdate.com/GKS2.

2011

Tanghetti, E.A.; Oefelein, M.: Unexpected Benefits of Topical Dapsone or Clindamycin/Benzoyl Peroxide in Combination with a Retinoid in the Treatment of Comedonal Acne. Poster presented to AAD February 2011

2010

Tanghetti, E.A. et al.: Pushing the Spectrum Optimizing Treatment of Vascular and Pigmented Lesions. Dermatology Times Suppl. Dec 2010

2010

Harper, J.; Oefelein, M.; Tanghetti, E.A.: The Efficacy and Tolerability of Dapsone 5% Gel in Female Versus Male Patients withFacial Acne Vulgaris: Gender as a Clinically Relevant Outcome Variable. Poster presented to Fall Clinical Dermatology 2010.

2010

Tanghetti, E.A.; Dhawan, S.; Green, L.: Randomized Comparison of the Safety and Efficacy of Tazarotene 0.1% Cream and Adapalene 0.3% Gel in the Treatment of Patients with at Least Moderate Facial Acne Vulgaris. JDD  9:549-558

2010

Tanghetti, E.A.: Randomized Comparison of Tazarotene 0.1% Cream and Adapalene 0.3% Gel in Patient with at Least Moderate Facial Acne Vulgaris and Postinflammatory Hyperpigmentation (PIH). Poster presented to Maui Derm 2010.

2009

Tanghetti, E.A.: Fixed-Combination Clindamycin 1% Benzoyl Peroxide 5% Hydrating Gel: A Flexible Component of Acne Management Cutis 84 5S:18-24

2009

Kircik, L; Green, L; Thiboutot, D; Tanghetti, E; et al: Comparing a Novel Solubolized Benzoyl Peroxide Gel with Benzoyl Peroxide/Clindamycin: Final Data From a Multicenter, Investigator-Blind, Randomized Study JDD Vol 8 9:812-818

2009

Tanghetti, E.A.: The Role of Topical Vitamin D Modulators in Psoriasis Therapy Journal of Drugs in Dermatology Vol 8 8:s4-s8

2009

Dover, J.S.; Baumann, L.; Bikowski, J.; Callendar, V.D.; Kandula, M.; Lupo, M.; Tanghetti, E.A.: A Stepwise Approach to Melasma Management and Treatment Cosmetic Dermatology Vol 22 2:81-88

2009

Antibiotic Use in Dermatology Dermatologic Clinics Chapter 27 A Current Review of Topical Benzoyl Peroxide: New Perspectives on Formulation and Utilization 1:17-24

2008

Tanghetti, E.A.: The Evolution of Benzoyl Peroxide Therapy. Cutis 82 5S:3-11

2008

Thiboutot, D.; Shalita, A.; Swinyer, L.; Tschen, E.; Eichenfield, L.; Del Rosso, J.; Tanghetti, E.: Comparison of a 3-Step Acne System Containing Solubilized Benzoyl Peroxide Versus Benzoyl Peroxide/CLindamycin: A Multicenter Investigator-Blind, Randomized Study (6week analysis of interim Data). Poster presented to American Academy of Dermatology Chicago, IL.

2008

Tanghetti, E.A.; Kircik, L.; Wilson, D.; Dhawan, S.: Solubilized Benzoyl Peroxide Versus Benzoyl Peroxide/Clindamycin in the Treatment of Moderate Acne. Journal of Drugs in Dermatology Vol 7, No 6:534-538

2008

Lloyd, J., Tanghetti, E.A.: Comparison of Affirm 1320/1440nm versus 1320nm for the Treatment of Acne Scars-A Clinical and Histological Study. Poster Presenting to the American Society for Laser Medicine and Surgery.

2008

Lloyd, J.; Tanghetti, E.A.: Comparison of Affirm 1320/1440 nm Versus 1320 nm For the Treatment of Acne Scars – A Clinical and Histological Study. Lasers in Surgery and Medicine 20:66

2008

Tanghetti, E.A.: Treatment of Photorejuvenation and Skin Laxity Using Sequential Emissions of Wavelengths-A Clinical and Histological Study. Poster Presenting to the American Society for Laser Medicine and Surgery.

2008

Tanghetti, E.A.: Treatment of Photorejuvenation and Neck Laxity Using Sequential Emmisions of Wavelengths – A Clinical and Histological Study. Lasers in Surgery and Medicine 20:281

2008

Tanghetti, E.A., Draelos, Z., Grimes, P., Dhawan, S., Gold, M., Kircik, L., Green, L., Moore, A., Cook-Bolden, F.: Moisturizer Use Enhances Facial Tolerability of Tazarotene 0.1% Cream Without Compromising Efficacy in Patients with Acne Vulgaris. Poster Presented 32^nd Hawaii Dermatology Seminar.

2008

Tanghetti, E.A., Kircik, L., Wilson, D., Dhawan, S.: Comparison of a Novel Solubilized Benzoyl Peroxide Gel with Benzoyl Peroxide/Clindamycin: A Multicenter, Investigator-Blind, Randomized Study. Poster Presented to the American Academy of Dermatology Meeting.

2008

Nash, K., Tanghetti, E.A.:  Fractional Lasers Retinoids, Varying Wavelengths Optimize Results.  Dermatology Times  Vol 29, No. 1, 68

2007

Hilten, L.; Tanghetti, E.A.: The Practice Newsletter. Dermatology Times September:66

2007

Kronemyer, B.; Tanghetti, E.A.: MedLite C6 PhotoAcoustic Therapy Improves Acne Scars. Aesthetic Buyers Guide July/August:60

2007

Tanghetti, E.A.; Dhawan, S.S.: Combined Effects of Benzoyl Peroxide 5%/Clindamycin 1% Gel with Tretinoin .025% Cream Compared to Use of 1% Clindamycin Gel, Tretinoin .025% Cream and 5% Benzoyl Peroxide Wash in the Treatment of Acne Vulgaris. Poster Presented in August at American Academy of Dermatology Meeting New York.

2007

Tanghetti, E.A.; Dhawan, S.; Torok, H.; Kircik, L.: Tazarotene 0.1 Percent Gel Versus Tretinoin 0.025 Percent Gel Plus Clindamycin 1 Percent Gel in the Treatment of Facial Acne Vulgaris. Dermatology Online J. Jul 13;13(3):1

2007

Tanghetti, E.A.: Improving Tolerability While Maintaining Efficacy: Practical Tips Skin & Allergy News Supplement July 1-2

2007

Tanghetti, E.A.: The Impact and Importance of Resistance. Cutis 80:3-9

2007

Tanghetti, E.A.; Werschler, W.P.: Comparison of 5% 5-Fluorouracil Cream and 5% Imiquimod Cream in the Management of Actinic Keratoses on the Face and Scalp. Journal of Drugs in Dermatology 6:144-147

2007

Wilson, F.; Biesman, B.; Katz, B.; Tanghetti, E.A.; Weiss, R.:Affirm Provides Persistent results without Maintenance Treatment. Aesthetic Buyers Guide March/April:4-7

2007

Tanghetti, E.A.; Weiss, R.: Multicenter Study of Microthermal Laser Treatment of Acne Scars. Lasers in Surgery & Medicine Suppl 19:112

2007

Adrian, RM; Tanghetti, EA: Multicenter Evaluation of Cynergy Multiplex Laser Treatment of Leg Veins. Lasers in Surgery & Medicine Suppl 19:77

2006

Tanghetti, E.A. et al: Cynergy with Multiplex Provides Double Effect for Vascular Lesions. Aesthetic Buyers Guide Clinical Roundtable Supplement.

2006

Lowe, N; Horwitz, S; Tanghetti, E; Draelos, Z; Menter, A: Tazaratene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: A multicenter, double-blind, randomized study. Journal of Cosmetic and Laser Therapy 8: 121-127

2006

Mirkov, M; Sherr, EA; Sierra, RA; Lloyd, JA; Tanghetti, EA; Analytical modeling of laser pulse heating of embedded biological targets: An application to cutaneous vascular lesions. Journal of Applied Physics 2006;99:114701.1-114701.15

2006

Bikowski, J; Callender, V.D.; Del Rosso, J.Q.; Draelos, Z.D.; Tanghetti, E.A: Combining Clindamycin 1% Benzoyl Peroxide 5% Gel With Multiple Therapeutic Options. Cutis 78 2S:13-20

2006

Tanghetti, E.A.: Treatment Options for Vascular Lesions. Skin & Aging Supplement January:13-16

2006

Tanghetti, E.A.: Open-Label Evaluation of 5% Benzoyl Peroxide/1% Clindamycin Gel Used in Combination with Tazarotene0.1% Cream and Oral Minocycline in the Treatment of Severe Acne Vulgaris. Poster Presented American Academy of Dermatology March

2006

Tanghetti, E.A.: The Importance of Vehicle and Skin Barrier Function in Acne Vulgaris. Skin & Allergy News Supplement June:3-5

2006

Tanghetti, E.A.: Topical Retinoids: the Misplaced Key to Treating Photodamaged Skin. Cosmetic Dermatology 19:364-368

2006

Tanghetti, E.A., Solomon, B., Loven, K., and Shalita, A.:  Tazarotene Versus Tazarotene Plus Clyndamycin/Benzoyl Peroxide in the Treatment of Acne Vulgaris, A Multi-Center, Double-Blind, Randomized Parallel-Group Trial.  Journal of Drugs in Dermatology  5:256-261

2006

Del Rosso, J.Q. and Tanghetti, E.A.:  The Clinical Impact of Vehicle Technology Using a Patented Formulation of Benzoyl Peroxide 5%/Clindamycin 1% Gel, Comparative Assessments of Skin Tolerability and Evaluation of Combination Use with a Topical Retinoid.  Journal of Drugs in Dermatology 5:160-164

2006

Tanghetti, E.A., Sherr, E.A., Sierra, R., and Mirkov, M.:  The Effects of Pulse Dye Laser Double-Pass Treatment Intervals on Depth of Vessel Coagulation.  Lasers in Surgery and Medicine  38:16-21

2006

Willey, A., Anderson, R.R., Azpiazu, J.L., Bakus, A.D., Barlow, R.J., Dover, J.S., Garden, J.M., Kilmer, S.L., Landa, N., Manstein, D., Ross, E.V., Sadick, N., Tanghetti, E.A., Taghmai, D., and Zelickson, B.D.:  Complications of Laser Dermatologic Surgery.  Lasers in Surgery and Medicine  38:1-15

2005

Adrian R, Tanghetti E, Kauvar ANB Long Pulsed KTP Lasers in: Kauvara ANB ed Principles and Practices of Cutaneous Laser Surgery. New York Taylor & Francis.

2005

Tanghetti, E.A.:  The Use of Topical Retinoids with Combination Therapies in the Management of Acne Vulgaris, Maximizing Results in the Treatment of Acne and Improving Facial Appearance.   Skin & Allergy News  6-7

2005

Tanghetti, E.A.: The Importance of the Vehicle in Protecting the Skin Barrier and Maximizing the Benefits of Acne Therapy. Skin & Aging Aug:75-77

2005

Tanghetti, E.A., Webster, G.F., Del Rosso, J.Q. and Callender, V.D.:  Combination Therapy is the Standard of Care.  Cutis  Vol 76 3, 8-14

2005

Tanghetti, E.A., Berson, D.S., Gold, M.H., Lupo, M.P. and Solomon, B.A.:  Acne Vulgaris and Rosacea, Optimizing Therapy.  Skin & Allergy News.